The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy
Clinical trial NCT03851913 · UNKNOWN
Trial details
- NCT number
- NCT03851913
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2022-08-31
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.